173142-47-7

Basic information

• Product Name: 2H-Pyrrole-2-carboxylicacid,3,4-dihydro-5-methoxy-,methylester,(2S)-(9CI)
• Synonyms: 2H-Pyrrole-2-carboxylicacid,3,4-dihydro-5-methoxy-,methylester,(2S)-(9CI);methyl(S)-5-methoxy-3,4-dihydro-2H-pyrrole-2-carboxylate
• CAS NO: 173142-47-7
• Molecular Formula: C₇H₁₁NO₃
• Molecular Weight: 157.17
• Product Categories: CARBOXYLICESTER
• Mol File: 173142-47-7.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2H-Pyrrole-2-carboxylicacid,3,4-dihydro-5-methoxy-,methylester,(2S)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2H-Pyrrole-2-carboxylicacid,3,4-dihydro-5-methoxy-,methylester,(2S)-(9CI)(173142-47-7)
• EPA Substance Registry System: 2H-Pyrrole-2-carboxylicacid,3,4-dihydro-5-methoxy-,methylester,(2S)-(9CI)(173142-47-7)

Safety Data

• Hazardous Substances Data: 173142-47-7(Hazardous Substances Data)

Usage

General Description

2H-Pyrrole-2-carboxylic acid, 3,4-dihydro-5-methoxy-, methyl ester, (2S)-(9CI) is a chemical compound with the molecular formula C9H11NO3. It is a derivative of pyrrole, which is a five-membered heterocyclic ring containing a nitrogen atom. The presence of a methoxy group and a methyl ester group in the compound indicates that it has potential applications in organic synthesis and medicinal chemistry. The compound may possess biological activity and could be used as a building block for the synthesis of other organic compounds with specific properties. Additionally, the stereochemistry of the molecule, with a specific 2S configuration, may be important for its interactions with biological receptors and enzymes. Overall, the compound has potential significance in medicinal and pharmaceutical research.

Upstream product

• 77-78-1 dimethyl sulfate 
• 4931-66-2 methyl (S)-pyroglutamate 
• 98-79-3 L-Pyroglutamic acid 
• 420-37-1 trimethoxonium tetrafluoroborate 

Downstream Products

• 467435-25-2 (3S,6R)-6-Benzyloxycarbonylamino-5-oxo-1,2,3,5,6,7-hexahydro-indolizine-3,8-dicarboxylic acid dimethyl ester 
• 467435-24-1 (3S,6S)-6-Benzyloxycarbonylamino-5-oxo-1,2,3,5,6,7-hexahydro-indolizine-3,8-dicarboxylic acid dimethyl ester 
• 125712-98-3 (S)-5-[1-Benzyloxycarbonyl-meth-(Z)-ylidene]-pyrrolidine-2-carboxylic acid methyl ester 
• 87896-52-4 (-)-A58365A 
• 125659-60-1 (S)-6-(2-Carboxy-ethyl)-5-oxo-1,2,3,5,6,7-hexahydro-indolizine-3,8-dicarboxylic acid 8-benzyl ester 3-methyl ester 
• 125659-62-3 (S)-6-(2-Methoxycarbonyl-ethyl)-5-oxo-1,2,3,5-tetrahydro-indolizine-3,8-dicarboxylic acid 8-benzyl ester 3-methyl ester 
• 125659-61-2 (S)-6-(2-Methoxycarbonyl-ethyl)-5-oxo-1,2,3,5,6,7-hexahydro-indolizine-3,8-dicarboxylic acid 8-benzyl ester 3-methyl ester 
• 229640-43-1 phenylmethyl 3-(8-hydroxy-5-oxo-3-(benzyloxycarbonyl)-1,2,3-trihydroindolizin-6-yl)propanoate 
• 676148-40-6 methyl (1R,2R,5S)-4-oxo-3,8-diazabicyclo[3.2.1]octane-2-carboxylate 
• 1190392-23-4 methyl [6(S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-α]]pyrimidine-6-carboxylate 
• 1190709-67-1 methyl (7S)-9-oxo-3,8-diazatetracyclo[9.2.1.0(2,10).0(4,8)]tetradeca-3,12-diene-7-carboxylate 
• 1190393-25-9 tert-butyl(2R,5S)-2-[(R)-hydroxy(phenyl)methyl]-5-[4-({[(6S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-α]pyrimidin-6-yl]carbonyl}amino)benzyl]pyrrolidine-1-carboxylate 
• 1190389-15-1 (6S)-N-[4-({(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl}methyl)phenyl]-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide 
• 1190392-22-3 (6S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-α]pyrimidine-6-carboxylic acid 

Relevant articles and documents

RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF

The present invention discloses a receptor inhibitor of formula (I), a pharmaceutical composition comprising the same and the use thereof.

A process for producing an intermediate agonist GRK 3

The present invention is directed to processes for preparing beta 3 agonists of Formula (I) and Formula (II) and their intermediates. The beta 3 agonists are useful in the treatment of certain disorders, including overactive bladder, urinary incontinence, and urinary urgency.

Synthesis of an azabicycloalkane amino acid scaffold as potential rigid dipeptide mimetic

Short syntheses are presented of the pseudo-dipeptide (3S,6S)-6-[(benzyloxy)carbonyl]amino-5-oxo-1,2,3,5,6,7-hexahydro-3- indolizinecarboxylic acid (1a) and of its (3S,6R) diastereoisomer (1b). The key step involves adding vinylogous β-enaminoester derived from pyroglutamic acid on an acrylate derivative. The 6,5-fused bicyclic lactam obtained may be viewed as a conformationally restricted Ala-Pro mimetic.